Table 4.
Compliance to Referral and Management of DR Patients Screened at CHC and PHC
| Screening at CHC No. of Persons (%) (n=4481) | Screening at PHC No. of Persons (%) (n=3678) | Total Screening No. of Persons (%) (n=8159) | Significance | |
|---|---|---|---|---|
| Referred | 997 (22.25) | 828 (22.51) | 1821 (22.32) | |
| Attended Base Hospital | 618 (13.79) | 624 (16.97) | 1242 (15.22) | |
| Compliance | 61.98% | 75.36% | 68.20% | |
| Investigated at Base Hospital | ||||
| For DR | 370 (8.26) | 401 (10.90) | 771 (9.45) | |
| For Ocular co-morbidity | 179 (3.99) | 292 (7.94) | 471 (5.77) | |
| Treatment for DR | 106 (29.94) | 143 (34.29) | 249 (32.30) | |
| LASER (PRP/Grid) | 52 (14.69) | 76 (18.23) | 128 (51.41) | P>0.05 (Not Significant) |
| Anti-VEGF Inj | 42 (11.86) | 56 (13.43) | 98 (39.36) | |
| LASER + anti - VEGF Inj | 12 (3.39) | 11 (2.64) | 23 (9.24) |